尿石素A
TL;DR: 尿石素A (CAS 1143-70-0) is a chemical compound with molecular formula C13H8O4 and molecular weight 228.04 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
尿石素A
3,8-dihydroxybenzo[c]chromen-6-one
Also Known As: urolithin A, 3,8-dihydroxy-6H-benzo[c]chromen-6-one, Mitopure, 3,8-Dihydroxyurolithin, urolithin-A
| Molecular Formula | C13H8O4 |
|---|---|
| Molecular Weight | 228.04 g/mol |
| LogP | 2.3574 |
| Topological Polar Surface Area | 70.67 Ų |
| Hydrogen Bond Donors | 2 |
| Hydrogen Bond Acceptors | 4 |
| Rotatable Bonds | 0 |
| Exact Mass | 228.04225 |
| Heavy Atoms | 17 |
| Complexity | 786.3709 |
Chemical Identifiers
| CAS Number | 1143-70-0 |
|---|---|
| SMILES | C1=CC2=C(C=C1O)C(=O)OC3=C2C=CC(=C3)O |
Product Overview
尿石素A (CAS 1143-70-0), with molecular formula C13H8O4 and molecular weight 228.04 g/mol. IUPAC: 3,8-dihydroxybenzo[c]chromen-6-one.
Chemical Property Profile of 尿石素A
Property Insights of 尿石素A
The XLogP value of 2.3574 suggests moderate lipophilicity, balancing water solubility and membrane permeability for 尿石素A. The TPSA of 70.67 Ų falls within the moderate polarity range, balancing permeability and solubility for 尿石素A. Following Lipinski's Rule of Five, 尿石素A has 2 hydrogen bond donor(s) and 4 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 尿石素A?
The CAS number of 尿石素A is 1143-70-0.
What is the molecular formula of 尿石素A?
The molecular formula of 尿石素A is C13H8O4.
What is the molecular weight of 尿石素A?
The molecular weight of 尿石素A is 228.04 g/mol.
Where can I buy 尿石素A?
You can request a quote for 尿石素A directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 尿石素A?
Yes, KEHONG BIO provides custom synthesis services for 尿石素A and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.